meglumine has been researched along with Leishmaniasis, Mucocutaneous in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (22.81) | 18.7374 |
1990's | 10 (17.54) | 18.2507 |
2000's | 13 (22.81) | 29.6817 |
2010's | 21 (36.84) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cupolillo, E; Dávila, AM; Ribeiro-Alves, M; Romero, GA; Torres, DC | 1 |
Blum, JA; Hatz, C; Mosimann, V; Neumayr, A | 1 |
Aoun, K; Badri, T; Ben Abda, I; Benmously-Mlika, R; Bouratbine, A; Chelbi, H; Fenniche, S; Hammami-Ghorbel, H; Mokhtar, I | 1 |
Caro-Gutiérrez, D; Gamo Villegas, R; López-Estebaranz, JL; Pampín Franco, A; Pinedo, F | 1 |
Barrio, A; Basombrio, MA; Beckar, J; Garcia Bustos, MF; Moreno, S; Parodi, C | 1 |
Confort, EM; da Costa, DC; da Silva, AF; Madeira, Mde F; Martins, AC; Moreira, JS; Palmeiro, MR; Quintella, LP; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM | 1 |
Aguirre-Urizar, JM; Araluce-Iturbe, I; Crovetto-De la Torre, MA; Crovetto-Martínez, R; Orte-Aldea, C; Whyte-Orozco, J | 1 |
Baños, I; Chicharro, C; Cuervas-Mons, V; García-Domínguez, J; Martinez-Ruiz, R; Múñez, E; Ramos, A; Suarez-Massa, D | 1 |
Joob, B; Wiwanitkit, V | 1 |
Barrio, A; Basombrío, MÁ; Bustos, MF | 1 |
Azzabi, S; Boukhris, I; Cherif, E; Kechaou, I | 1 |
Albuquerque, DR; Cruz, AF; de Lacerda, JC; Ferreira Aguiar, MC; Leite, CF; Resende, RG | 1 |
Handjani, F; Hatam, GR; Mohammadpour, I; Motazedian, MH | 1 |
Barnabas, GA; Morrone, A; Padovese, V; Terranova, M; Toma, L | 1 |
Abegão de Camargo, R; Amato, VS; Duarte, MI; Imamura, R; Neto, VA; Tuon, FF | 1 |
Buffet, PA; Caumes, E; Jauréguiberry, S; Jeddi, F; Mazier, D; Thellier, M | 1 |
El Fékih, N; Fazaa, B; Kamoun, MR; Khaled, S; Kharfi, M; Sliti, N; Trabelsi, S | 1 |
Figueroa, RA; Miranda, MC; Prager, M; Zea, DF | 1 |
Dorlo, TP; Kager, PA | 1 |
Brahn, E; Craft, N; Pegues, DA; Yao, Q | 1 |
Araujo-Melo, MH; Araújo-Silva, M; Carmo, CN; Conceição-Silva, F; Meneses, AM; Moreira, JS; Oliveira, RV; Pimentel, MI; Salgueiro, MM; Schubach, AO; Valete-Rosalino, CM | 1 |
Amarti, A; Harmouche, T; Iguermia, S; Mernissi, FZ; Mikou, O | 1 |
Di Mauro, D; Petrillo, G; Viglianesi, A | 1 |
Chrusciak Talhari, C; Chrusciak-Talhari, A; da Silva, RM; de Oliveira Penna, G; Dietze, R; Gadelha Yamashita, EP; Lima Machado, PR; Talhari, S | 1 |
Karoui, S; Osman, AB; Zaraa, I | 1 |
Abebe, Z; Dassoni, F; Morrone, A; Naafs, B | 1 |
Arruda, D; Foss, NT; Motta, AC; Souza, CS | 1 |
Bermúdez, H; Boelaert, M; Chappuis, F; Desjeux, P; Dujardin, JC; Garcia, L; Rojas, E | 1 |
Alvarez, E; Bryceson, A; Campos, P; Chang, E; Cruz, M; Echevarria, J; Llanos-Cuentas, A; Rosales, E; Seas, C | 1 |
Amato, VS; Neto, VA; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER | 1 |
Barreto, AC; Cuba, CC; Llanos Cuentas, EA; Marsden, PD | 1 |
Armas, JA; Moreno, G; Rezzano, S; Scorza, JV | 1 |
Barreto, AC; Cuba, CC; Guerra, M; Magalhâes, A; Marsden, PD; Rocha, RA; Sampaio, RN | 1 |
Avila, JL; Biondo, F; Convit, J; Monzón, H | 1 |
Berman, JD; Franke, ED; Gasser, RA; Grögl, M; Magill, AJ; Oster, CN | 1 |
Berman, J; Grogl, M; Hernandez, N; Mejia, H; Soto, J | 1 |
Harto, A; Hilara, Y; Ledo, A; Miralles, ES; Moreno, R; Núñez, M | 1 |
Escobar, MA; Saravia, NG; Weigle, KA | 1 |
Barbosa Santos, EG; Barroso, JA; Brito, CM; Conceição, NF; Marzochi, MC; Pacheco, RS | 1 |
Blackwell, JM; Cabrera, M; Castes, M; Convit, J; Shaw, MA; Trujillo, D | 1 |
Cuba Cuba, CA; Howard, MK; Miles, MA; Ogunkolade, W | 1 |
Anacleto, C; Andrade, AF; Ferreira, AV; Gazola, KC; Michalick, MS; Moreira, ES | 1 |
Bagán, JV; Jiménez, Y; Milián, MA; Pérez, A; Scully, C | 1 |
Barrios, AA; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V | 1 |
Franke, ED; Grogl, M; Thomason, TN | 1 |
da Costa, CA; Dias, M; Genaro, O; Lima, Ade O; Magalhaes, PA; Mayrink, W; Melo, MN; Michalick, MS; Nascimento, E; Toledo, VP | 1 |
Chapman, WL; Hanson, WL; Lovelace, JK; Waits, VB | 1 |
Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB | 1 |
Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE | 1 |
Carvalho, EM; Costa, JL; Llanos-Cuentas, EA; Marsden, PD; Sampaio, RN; Veiga, JP | 1 |
Chong, H | 1 |
Marsden, PD | 1 |
Costa, JM; Dorea, JG; Holzbecher, J; Marsden, PD; Ryan, DE | 1 |
Barrios, LA; Costa, JM; Cuba, CC; Marsden, PD; Netto, EM; Vexenat, CO | 1 |
Amendoeira, RR; Coutinho, SG; Marzochi, MC; Mendonça, SC; Pirmez, C | 1 |
Barral, A; Barreto, AC; Carvalho, EM; Costa, JM; Cuba, CC; Llanos-Cuentas, EA; Magalhães, AV; Marsden, PD; Netto, EM; Rosa, AC | 1 |
4 review(s) available for meglumine and Leishmaniasis, Mucocutaneous
Article | Year |
---|---|
Lip leishmaniasis: a case series with molecular identification and literature review.
Topics: Adult; Aged; Animals; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Iran; Leishmania infantum; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae; Treatment Outcome | 2017 |
Treatment of mucosal leishmaniasis in Latin America: systematic review.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Latin America; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Paromomycin; Pentamidine | 2007 |
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin | 1986 |
Mucosal leishmaniasis ("espundia" Escomel, 1911).
Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
5 trial(s) available for meglumine and Leishmaniasis, Mucocutaneous
Article | Year |
---|---|
[Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Comparative Effectiveness Research; Female; Humans; Injury Severity Score; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nasopharynx; Organometallic Compounds; Phosphorylcholine; Young Adult | 2014 |
Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Treatment Outcome; Young Adult | 2011 |
Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Humans; Infusions, Parenteral; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Nasal Mucosa; Organometallic Compounds; Paromomycin | 2007 |
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin | 1995 |
Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil.
Topics: Adolescent; Adult; Aged; Animals; Brazil; Child; Child, Preschool; Female; Humans; Immunotherapy, Active; Leishmania; Leishmania guyanensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Protozoan Vaccines | 1992 |
48 other study(ies) available for meglumine and Leishmaniasis, Mucocutaneous
Article | Year |
---|---|
Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
Topics: Amino Acid Substitution; Animals; Antiprotozoal Agents; Base Sequence; Brazil; DNA, Protozoan; Drug Resistance; Genetic Markers; HSP70 Heat-Shock Proteins; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Molecular Sequence Data; Mutation; Organometallic Compounds; Polymorphism, Genetic; Prognosis; Protozoan Proteins; Sequence Analysis, DNA; Treatment Outcome | 2013 |
Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Retrospective Studies; Species Specificity; Switzerland; Travel; Treatment Outcome; Young Adult | 2013 |
Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia.
Topics: Adolescent; Adult; Antiprotozoal Agents; Cheilitis; Combined Modality Therapy; Communicable Diseases, Emerging; Cryotherapy; Female; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Mucocutaneous; Lip; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Tunisia; Young Adult | 2015 |
Mucosal leishmaniasis of the tongue caused by Leishmania infantum in an immunocompetent woman.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tongue Diseases | 2015 |
Oral manifestations in the American tegumentary leishmaniasis.
Topics: Antiprotozoal Agents; Female; Humans; Larynx; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nose; Nose Diseases; Organometallic Compounds; Pharynx; Prognosis; Retrospective Studies | 2014 |
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Combined Modality Therapy; Diagnosis, Differential; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Nose Diseases; Organometallic Compounds | 2015 |
Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient.
Topics: Antiprotozoal Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Liver Transplantation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth; Organometallic Compounds; Polymerase Chain Reaction | 2015 |
[Miltefosine or meglumine antimoniate in leishmaniasis].
Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Organometallic Compounds; Phosphorylcholine | 2015 |
[More about miltefosine in the treatment of mucosal leishmaniasis].
Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Organometallic Compounds; Phosphorylcholine | 2015 |
Orofacial granulomatosis: do not forget leishmaniasis.
Topics: Antiprotozoal Agents; Diagnosis, Differential; Granulomatosis, Orofacial; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2015 |
Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
Topics: Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Brazil; Fatal Outcome; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Mucosa; Organometallic Compounds; Polymerase Chain Reaction; Skin Tests | 2016 |
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; HIV Infections; HIV-1; Humans; Infant; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Socioeconomic Factors; Young Adult | 2009 |
Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiprotozoal Agents; Brazil; Case Management; Cohort Studies; Female; Humans; Hypertension; Itraconazole; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Logistic Models; Male; Meglumine; Middle Aged; Pentamidine; Retrospective Studies; Risk Factors; Secondary Prevention; Skin; Treatment Failure; Young Adult | 2009 |
Drug hypersensitivity syndrome induced by meglumine antimoniate.
Topics: Adult; Antiprotozoal Agents; Drug Hypersensitivity; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Syndrome | 2009 |
[Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].
Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Tunisia | 2008 |
[Mucosal complication of cutaneous leishmaniasis].
Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds; Phosphorylcholine | 2009 |
Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
Topics: Antiprotozoal Agents; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Pentamidine | 2010 |
Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Brazil; California; Diagnosis, Differential; Female; Granulomatosis with Polyangiitis; Humans; Infusions, Intravenous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Referral and Consultation | 2010 |
Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Mucocutaneous; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Odds Ratio; Organometallic Compounds; Retrospective Studies; Risk Factors; Sex Distribution; Young Adult | 2010 |
[Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].
Topics: Adolescent; Africa; Antiprotozoal Agents; Biological Evolution; Cheilitis; Host-Parasite Interactions; Humans; Immunocompetence; Latin America; Leishmania; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Species Specificity; Virulence | 2011 |
Multidetector computed tomography aspects of tracheal mucosal leishmaniasis localization.
Topics: Aged; Antiprotozoal Agents; Bronchoscopy; Contrast Media; Humans; Imaging, Three-Dimensional; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed; Tracheal Diseases | 2011 |
Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World.
Topics: Adolescent; Adult; Antiprotozoal Agents; Humans; Injections, Intralesional; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2012 |
Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation?
Topics: Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Endemic Diseases; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leprosy, Tuberculoid; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2013 |
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Topics: Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Humans; Immunocompromised Host; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2003 |
Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bolivia; Drugs, Generic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2006 |
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1983 |
Clinical characteristics of human Leishmania braziliensis braziliensis infections.
Topics: Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mucous Membrane; Organometallic Compounds | 1984 |
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors | 1984 |
Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
Topics: Amphotericin B; Antigens; Antimony; Brazil; Female; Fluorescent Antibody Technique; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1980 |
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol | 1982 |
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
Topics: Adult; Amylases; Antimony Sodium Gluconate; Antiprotozoal Agents; District of Columbia; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Peru; Prospective Studies | 1994 |
Mucocutaneous leishmaniasis and HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
Concurrent mucosal leishmaniasis and pulmonary tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Contraindications; Drug Therapy, Combination; Humans; Immunity, Cellular; Isoniazid; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1996 |
N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy.
Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dogs; Female; Immunity, Cellular; Injections, Intralesional; Isoenzymes; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1998 |
Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; BCG Vaccine; Cell Division; Combined Modality Therapy; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-5; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Protozoan Vaccines; T-Lymphocytes, Helper-Inducer; Th1 Cells; Tuberculin | 2000 |
Immunological selection for Leishmania (Viannia) braziliensis antigens.
Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Biomarkers; Blotting, Western; Case-Control Studies; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2001 |
Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
Topics: Animals; Antimony; Antiprotozoal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cricetinae; Disease Models, Animal; Drug Resistance; Glycosphingolipids; Lectins; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 2001 |
Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; Hepatitis C; Humans; Injections, Intravenous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Mouth Mucosa; Organometallic Compounds; Palate, Hard | 2002 |
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Naphthoquinones; Organometallic Compounds; Plant Extracts | 1992 |
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1991 |
Berberine derivatives as antileishmanial drugs.
Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1990 |
Retention of antimony in hair during leishmaniasis treatment.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Administration Schedule; Hair; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1989 |
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
Topics: Adult; Amphotericin B; Antimony; Antimony Sodium Gluconate; Child; Gluconates; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
Antimony accumulation in hair during treatment of leishmaniasis.
Topics: Antimony; Brazil; Hair; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Neutron Activation Analysis; Organometallic Compounds; Retrospective Studies; Sorbitol | 1987 |
Intralesional glucantime in Leishmania braziliensis braziliensis infections.
Topics: Adult; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy.
Topics: Adult; Antigens, Protozoan; Concanavalin A; Drug Resistance, Microbial; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Lymphocyte Activation; Meglumine; Skin; Sorbitol | 1986 |
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |